🇺🇸 MRK — Merck & Co., Inc.

Salud Compra
← Volver

Precio actual

146,73 USD

Máx. histórico

156,45

73 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-6,21%

Rango 52 semanas

85,24 – 156,92

Variación hoy

-0,14%

Cierre anterior

146,94

Rango de hoy

142,80 – 147,48

Volumen hoy

7.462.267

Peor caída histórica

-68,62%

28/12/2000 → 09/03/2009

Recuperado en 1796 días

Volatilidad anualizada ⓘ

25,43%

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
148,21 (puede no estar actualizado)
Dividend yield
2,31% (puede no estar actualizado)
Precio objetivo analistas
161,53 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 7 horas
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,4000 USD · Yield: 2,32%
Fecha de pago Importe por participación
15/09/2026 0,8500 USD
15/06/2026 0,8500 USD
16/03/2026 0,8500 USD
15/12/2025 0,8500 USD
15/09/2025 0,8100 USD
16/06/2025 0,8100 USD
17/03/2025 0,8100 USD
16/12/2024 0,8100 USD
16/09/2024 0,7700 USD
17/06/2024 0,7700 USD
14/03/2024 0,7700 USD
14/12/2023 0,7700 USD
14/09/2023 0,7300 USD
14/06/2023 0,7300 USD
14/03/2023 0,7300 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
29/12/2015 50,54 51,15 50,49 50,90 +0,95% 1,32% 6.925.708
28/12/2015 50,37 50,61 50,16 50,42 -0,02% 0,89% 5.068.442
24/12/2015 50,37 50,70 50,20 50,43 -0,25% 0,99% 3.123.145
23/12/2015 49,98 50,78 49,96 50,55 +1,69% 1,64% 7.469.515
22/12/2015 49,63 49,84 48,93 49,71 +0,44% 1,83% 13.830.351
21/12/2015 49,76 49,76 48,86 49,49 +0,45% 1,82% 12.194.633
18/12/2015 49,76 49,92 49,25 49,27 -1,94% 1,36% 22.114.686
17/12/2015 51,63 51,77 50,25 50,25 -2,52% 2,94% 14.165.921
16/12/2015 50,97 51,63 50,57 51,55 +2,12% 2,08% 10.494.986
15/12/2015 50,08 50,75 49,84 50,48 +1,34% 1,83% 12.142.023
14/12/2015 49,76 49,96 49,28 49,81 +0,10% 1,36% 12.575.162
11/12/2015 50,57 50,84 49,64 49,76 -2,87% 2,38% 10.896.999
10/12/2015 50,59 51,51 50,40 51,23 +1,65% 2,19% 12.001.591
09/12/2015 50,84 51,15 50,11 50,40 -1,22% 2,05% 10.854.346
08/12/2015 51,12 51,91 50,78 51,02 -0,39% 2,20% 7.936.714
07/12/2015 51,55 51,75 50,74 51,22 +0,07% 1,94% 9.113.408
04/12/2015 50,45 51,22 50,41 51,18 +2,00% 1,61% 14.343.976
03/12/2015 51,59 51,61 49,85 50,18 -2,29% 3,42% 14.247.665
02/12/2015 52,16 52,47 51,29 51,36 -1,37% 2,27% 10.584.066
01/12/2015 51,31 52,14 50,99 52,07 +2,94% 2,23% 13.620.646
30/11/2015 51,56 51,63 50,57 50,58 -1,76% 2,05% 14.004.634
27/11/2015 50,92 51,72 50,92 51,49 +0,45% 1,57% 3.124.717
25/11/2015 51,16 51,45 51,01 51,26 +0,45% 0,86% 6.370.687
24/11/2015 51,11 51,22 50,67 51,03 -0,98% 1,08% 11.011.546
23/11/2015 51,60 51,72 51,32 51,54 -0,17% 0,78% 9.105.129
20/11/2015 52,11 52,35 51,53 51,62 -0,33% 1,57% 9.362.098
19/11/2015 51,95 52,03 51,45 51,79 +0,09% 1,12% 7.167.482
18/11/2015 51,39 51,83 51,24 51,75 +0,97% 1,15% 11.330.347
17/11/2015 51,25 51,81 50,85 51,25 +0,02% 1,88% 7.468.677
16/11/2015 49,80 51,35 49,74 51,24 +1,26% 3,22% 7.239.374